BioMed Realty and Babraham Research Campus Announce Full Letting of Newest Life Science Development on Campus


Mosaic Therapeutics, an oncology therapeutics company and alumni of Accelerate@Babraham, has agreed to take ~6,800 square feet in the newest building on Babraham Research Campus. Mosaic recently closed a $28 million Series A funding round. They will be joined in the new building by Insmed and Xap Therapeutics, both companies are scaling up from existing space on the Campus.

Read the full press release here.